CD274 and pleural mesothelioma: We retrospectively evaluated the efficacy of nivolumab in patients with pleural mesothelioma and performed an integrated analysis of the TME, including PD‐L1 expression and the density and spatial distribution of TILs, using mIF to determine the association between the TME and the efficacy of ICIs.